Citigroup and Royal Bank of Canada raised price targets and ratings for a company, with MarketBeat aggregating the financial data.
4 reports, 2 independent
Updated Sep 14
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 4
- Developments
- 2
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Citigroup and Royal Bank of Canada raised price targets and ratings for a company, with MarketBeat aggregating the financial data.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.AbbVie benefits from increased institutional buying and analyst rating upgrades.1 source
Citigroup and RBC raised price targets and ratings for a company, with MarketBeat aggregating the data.1 source
Keep exploring
The entities involved
-
AbbVie
pharmaceutical company
-
Citigroup
American investment bank and financial services corporation
-
Royal Bank of Canada
financial institution in Canada
-
MarketBeat
American personal finance blog
Related events
- RBC and Citigroup boosted price objectives on Lockheed Martin shares, with MarketBeat aggregating the analyst ratings.
- Citigroup raised its target price and Royal Bank of Canada boosted its price objective for Carrier Global Corporation on August 26, 2026.
- Bank of America, Citigroup, and Royal Bank of Canada issued rating upgrades and price target increases for International Paper.
- RBC raised its target price for Howmet Aerospace, while Citigroup reiterated a 'buy' rating on the shares.
- Analyst firms RBC and Morgan Stanley set price targets for OTIS, with MarketBeat aggregating the ratings.